Northeast Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.2M Sell
170,118
-166
-0.1% -$38.7K 1.59% 19
2026
Q1
$41.6M Sell
170,284
-2,191
-1% -$510K 1.72% 18
2025
Q4
$35.7M Buy
172,475
+230
+0.1% +$45.5K 1.39% 21
2025
Q3
$31.9M Sell
172,245
-1,922
-1% -$329K 1.29% 24
2025
Q2
$26.6M Sell
174,167
-1,789
-1% -$275K 1.14% 31
2025
Q1
$29.2M Sell
175,956
-4,473
-2% -$700K 1.36% 24
2024
Q4
$26.1M Sell
180,429
-8,616
-5% -$1.34M 1.16% 26
2024
Q3
$30.6M Sell
189,045
-572
-0.3% -$91.1K 1.37% 24
2024
Q2
$27.7M Sell
189,617
-6,372
-3% -$948K 1.3% 24
2024
Q1
$31M Sell
195,989
-928
-0.5% -$148K 1.52% 22
2023
Q4
$30.9M Sell
196,917
-1,891
-1% -$290K 1.65% 20
2023
Q3
$31M Sell
198,808
-15,342
-7% -$2.53M 1.82% 17
2023
Q2
$35.4M Sell
214,150
-4,006
-2% -$647K 2% 16
2023
Q1
$33.8M Sell
218,156
-2,894
-1% -$467K 2.05% 17
2022
Q4
$39M Sell
221,050
-2,637
-1% -$455K 2.49% 13
2022
Q3
$36.5M Sell
223,687
-2,228
-1% -$377K 2.47% 12
2022
Q2
$40.1M Buy
225,915
+1,152
+0.5% +$205K 2.56% 12
2022
Q1
$39.8M Buy
224,763
+1,545
+0.7% +$263K 2.1% 14
2021
Q4
$38.2M Sell
223,218
-3,299
-1% -$540K 1.86% 19
2021
Q3
$36.6M Buy
226,517
+1,992
+0.9% +$340K 1.95% 19
2021
Q2
$37M Sell
224,525
-1,186
-0.5% -$196K 1.99% 18
2021
Q1
$37.1M Buy
225,711
+572
+0.3% +$92.6K 2.19% 16
2020
Q4
$35.4M Buy
225,139
+53
+0% +$7.82K 2.16% 16
2020
Q3
$33.5M Buy
225,086
+2,396
+1% +$355K 2.23% 13
2020
Q2
$31.3M Buy
222,690
+2,259
+1% +$329K 2.34% 13
2020
Q1
$28.9M Sell
220,431
-6,865
-3% -$974K 2.65% 12
2019
Q4
$33.2M Sell
227,296
-4,355
-2% -$591K 2.44% 14
2019
Q3
$30M Sell
231,651
-6,638
-3% -$875K 2.4% 15
2019
Q2
$33.2M Buy
238,289
+2,834
+1% +$392K 2.64% 12
2019
Q1
$32.9M Sell
235,455
-1,008
-0.4% -$135K 2.76% 10
2018
Q4
$30.5M Sell
236,463
-4,091
-2% -$571K 2.94% 8
2018
Q3
$33.2M Sell
240,554
-4,592
-2% -$610K 2.65% 9
2018
Q2
$29.7M Sell
245,146
-1,764
-0.7% -$220K 2.52% 9
2018
Q1
$31.6M Sell
246,910
-2,549
-1% -$345K 2.8% 8
2017
Q4
$34.9M Sell
249,459
-3,422
-1% -$477K 2.93% 6
2017
Q3
$32.9M Sell
252,881
-4,005
-2% -$531K 2.91% 5
2017
Q2
$34M Buy
256,886
+7,555
+3% +$964K 3.09% 4
2017
Q1
$31.1M Sell
249,331
-2,756
-1% -$329K 2.91% 4
2016
Q4
$29M Buy
252,087
+230
+0.1% +$26.6K 2.79% 4
2016
Q3
$29.8M Buy
251,857
+2,971
+1% +$360K 2.97% 3
2016
Q2
$30.2M Buy
248,886
+1,333
+0.5% +$151K 3.04% 3
2016
Q1
$26.8M Buy
247,553
+9,171
+4% +$949K 2.75% 6
2015
Q4
$24.5M Sell
238,382
-224
-0.1% -$22.5K 2.54% 7
2015
Q3
$22.3M Sell
238,606
-1,099
-0.5% -$106K 2.4% 10
2015
Q2
$23.4M Buy
239,705
+1,204
+0.5% +$121K 2.36% 10
2015
Q1
$24M Sell
238,501
-323
-0.1% -$32.8K 2.35% 11
2014
Q4
$25M Buy
238,824
+12,330
+5% +$1.3M 2.44% 9
2014
Q3
$24.1M Buy
226,494
+3,959
+2% +$411K 2.43% 9
2014
Q2
$23.3M Buy
222,535
+282
+0.1% +$28.5K 2.34% 11
2014
Q1
$21.8M Sell
222,253
-1,182
-0.5% -$110K 2.32% 9
2013
Q4
$20.5M Buy
223,435
+463
+0.2% +$42.7K 2.29% 12
2013
Q3
$19.3M Buy
222,972
+1,017
+0.5% +$91.2K 2.35% 9
2013
Q2
$19.1M Buy
+221,955
New +$18.8M 2.44% 9

Other funds holding JNJ

Northeast Investment Management's JNJ Position: Q2 2026 in Review

Northeast Investment Management reduced its Johnson & Johnson (JNJ) stake by 0.1% in Q2 2026, selling an estimated $38.7K and leaving 170,118 shares worth $43.2M. The position accounts for 1.59% of the portfolio, ranked #19.

Northeast Investment Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 1,021 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Northeast Investment Management held 170,118 shares of Johnson & Johnson worth $43.2M as of Q2 2026.
  • Northeast Investment Management sold 166 Johnson & Johnson shares in Q2 2026, an estimated $38.7K.
  • Johnson & Johnson made up 1.59% of Northeast Investment Management's portfolio in Q2 2026, its #19 holding.
  • Northeast Investment Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1,021 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.